JP Stock MarketDetailed Quotes
4564 ONCOTHERAPY SCIENCE
- 15
- 00.00%
20min DelayMarket Closed May 17 15:00 JST
3.26BMarket Cap-2581P/E (Static)
16High15Low3.04MVolume16Open15Pre Close48.49MTurnover4552wk High1.63%Turnover Ratio217.64MShares1552wk Low-5.75EPS TTM2.79BFloat Cap863Historical HighLossP/E (Static)186.16MShs Float15Historical Low-5.81EPS LYR6.67%Amplitude--Dividend TTM4.98P/B100Lot Size--Div YieldTTM
About ONCOTHERAPY SCIENCE Company
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.
Company Profile
Symbol4564
Company NameONCOTHERAPY SCIENCE
Founded2001-04-06
MarketTSE Growth
Employees60
Fiscal Year Ends03-31
Address11th Floor, Kanagawa Science Park R&D 3-2-1 Sakado
Zip Code210-0005
Phone044-201-6429
Websitewww.oncotherapy.co.jp
Company Executives
- Name
- Position
- Salary
- Jae-Hyun Park
- President, Representative Director and Chief Scientific Officer
- --
- Junichi Shimada
- Director and General Manager of Corporate Planning Department
- --
- Hajio Kato
- Chairman of the Board
- --
- Yuichi Komine
- Independent Director
- --
- Yoshio Miki
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
%Chg